Based on this latest update could estimate full year NPAT of around $42 million. Based on market cap of around $650 million after today's 7% jump gives a PE of around 15. Not exceptionally high for a company achieving 30% NPAT growth over previous year. Dividends should also increase. This is in a great sector (health, beauty, pharmaceuticals), I would expect there is room for this stock to go quite a bit higher yet.
API Price at posting:
$1.31 Sentiment: Hold Disclosure: Held